Abbott’s studies show CGM technology linked to lower heart hospitalisation risk
Funded by the company, the studies utilised data from the Swedish National Diabetes Register.
Funded by the company, the studies utilised data from the Swedish National Diabetes Register.
Give your business an edge with our leading industry insights.